Voltage-Gated Potassium+ Channel Expression in Coronary Artery Smooth Muscle Cells of SHR and WKY

被引:2
|
作者
Hu, Zhi [1 ,2 ]
Ma, Aiqun [1 ,2 ]
Zhang, Yushun [1 ,2 ]
Xi, Yutao [1 ,2 ]
Fan, Lihong [1 ,2 ]
Wang, Tingzhong [1 ,2 ]
Zhang, Tingting [1 ,2 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Chinese Minist Educ, Key Lab Environm & Gene Related Dis, Xian 710061, Shaanxi, Peoples R China
关键词
Voltage-gated K+ channels; Hypertension; Artery; VASCULAR-RESISTANCE VESSELS; CA2+-ACTIVATED K+ CHANNEL; MESENTERIC-ARTERIES; NITRIC-OXIDE; MYOCYTES; INCREASES; CLONING;
D O I
10.1007/s12013-014-0120-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aims to compare the expression of genes and the molecular characteristic of voltage-gated K+ channels, which make great effort in maintaining and controlling smooth muscle contraction, cellular membrane potential, and intracellular calcium ion currents in artery smooth muscle cells of SHR and WKY. Expression of potassium ions family in coronary artery was detected through reverse transcription polymerase chain reaction quantitatively. Significant levels of voltage-gated K+ channels alpha 1.2, alpha 1.5, and beta 1.1 expression were all proved to be significantly higher in smooth muscles of SHR than WKY. Whole-cell voltage-gated K+ channel currents were larger in SHR artery smooth muscles than the ones of WKY. Moreover, the voltage dependence of voltage-gated potassium channel activation was more negative in artery smooth muscle of SHR than that of WKY, while voltage dependence of availability was not different. The above diversity of voltage-gated potassium channel detected in gene expression and electrical character in coronary artery smooth muscle of SHR than that of WKY might be an underling mechanism associated with the membrane potential depolarization in artery smooth muscle of SHR.
引用
收藏
页码:1725 / 1731
页数:7
相关论文
共 50 条
  • [11] Voltage-gated potassium channel inhibition attenuates phenylephrine-induced calcium oscillations in canine pulmonary artery smooth muscle cells
    Doi, S
    Damron, DS
    Murray, PA
    CIRCULATION, 1998, 98 (17) : 270 - 270
  • [12] Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells
    Wang, J
    Juhaszova, M
    Rubin, LJ
    Yuan, XJ
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09): : 2347 - 2353
  • [13] Developmental expression of voltage-gated potassium channel β subunits
    Downen, M
    Belkowski, S
    Knowles, H
    Cardillo, M
    Prystowsky, MB
    DEVELOPMENTAL BRAIN RESEARCH, 1999, 117 (01): : 71 - 80
  • [14] Voltage-gated Na+ channels in mesenteric artery smooth muscle cells
    Berra-Romani, R
    Blaustein, MP
    Matesson, DR
    FASEB JOURNAL, 2005, 19 (04): : A125 - A125
  • [15] Dysfunctional voltage-gated potassium channels in the pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension
    Yuan, XJ
    Aldinger, AM
    Orens, JB
    Conte, JV
    Rubin, LJ
    CIRCULATION, 1996, 94 (08) : 274 - 274
  • [16] The effect of protein kinase C on voltage-gated potassium channel in pulmonary artery smooth muscle cells from rats exposed to chronic hypoxia
    张永昶
    倪望
    张珍祥
    徐永健
    ChineseMedicalJournal, 2004, (01)
  • [17] The effect of protein kinase C on voltage-gated potassium channel in pulmonary artery smooth muscle cells from rats exposed to chronic hypoxia
    Zhang, YC
    Ni, W
    Zhang, ZX
    Xu, YJ
    CHINESE MEDICAL JOURNAL, 2004, 117 (01) : 19 - 23
  • [18] The effect of protein kinase C on voltage-gated potassium channel in pulmonary artery smooth muscle cells from rats exposed to chronic hypoxia
    张永昶
    倪望
    张珍祥
    徐永健
    中华医学杂志(英文版), 2004, (01) : 20 - 24
  • [19] Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells.
    Yuan, XJ
    Wang, J
    Juhaszova, M
    Rubin, LJ
    CIRCULATION, 1997, 96 (08) : 330 - 330
  • [20] Voltage-gated potassium channel inhibitors
    Hopkins, WF
    Miller, JL
    Miljanich, GP
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (04) : 389 - 396